Discover

PEN
Penumbra, Inc.
320.54
1 x 320.61
1 x 320.79
bid
ask
+
1.17
0.37%
02:00 PM
timesize
Ytd 3.10%
1y 25.54%
319.86
day range
323.10
221.26
52 week range
362.41
Open 322.94 Prev Close 319.37 Low 319.86 High 323.10 Mkt Cap 12.61B
Vol 423.95K Avg Vol 526.41K EPS 4.34 P/E 73.86 Forward P/E 50.66
Beta 0.73 Short Ratio 3.92 Inst. Own 87.95% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 07-28 50-d Avg 327.24 200-d Avg 304.38 1yr Est 363.36
Earning
Date For Estimate Reported Surprise surprise %
2026-05-06 2026-03 1.11 0.82 -0.29 -26.13%
2026-02-25 2025-12 1.12 1.18 0.06 5.36%
2025-11-05 2025-09 0.9 0.97 0.07 7.78%
2025-07-29 2025-06 0.81 0.86 0.05 6.17%
2025-04-23 2025-03 0.66 0.83 0.17 25.76%
2025-02-18 2024-12 0.91 0.97 0.06 6.59%
Upgrade / Downgrade
Date Firm Action From To
2026-05-07 Citigroup Upgrade Neutral Neutral
2026-05-07 Evercore ISI Group Upgrade Outperform Outperform
2026-02-26 Evercore ISI Group Upgrade Outperform Outperform
2026-01-20 RBC Capital Downgrade Outperform Sector Perform
2026-01-20 Canaccord Genuity Downgrade Buy Hold
2026-01-16 Jefferies Downgrade Buy Hold
Profile
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Insider Holder
Date Name Relation Quantity Description
2026-02-12 BOSE ARANI Director 259.61K Stock Award(Grant)
2026-05-18 ELSESSER ADAM Chief Executive Officer 0.00 Stock Gift
2026-04-01 GREWAL HARPREET SINGH Director 8.72K Sale
2025-02-13 KASSING DON W Director 9.91K Stock Award(Grant)
2026-02-12 LEEDS JANET Director 6.64K Stock Award(Grant)
2026-02-16 NARAYAN SHRUTHI President 30.87K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 4.33M 1.38B 11.01%
2026-03-30 Vanguard Capital Management LLC 1.69M 540.01M 4.31%
2026-03-30 Vanguard Portfolio Management LLC 1.65M 527.26M 4.21%
2026-03-30 HBK Investments L P 1.63M 520.81M 4.16%
2026-03-30 State Street Corporation 1.19M 377.90M 3.01%
2026-03-30 Millennium Management Llc 1.10M 349.96M 2.79%
Fund Ownership
Report Date Organization Position Value Percentage
2026-04-29 iShares Trust-iShares Core S&P Mid-Cap ETF 1.33M 422.31M 3.37%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.18M 377.35M 3.01%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 859.63K 273.95M 2.19%
2025-12-30 T. Rowe Price Health Sciences Fund, Inc. 536.11K 170.85M 1.36%
2026-02-27 VANGUARD WORLD FUND-Vanguard U.S. Growth Fund 502.94K 160.28M 1.28%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund 481.06K 153.31M 1.22%
Split
Split Date
1 : 10 2014-11-16